G.dezwaluw schreef op 5 maart 2021 09:08:
Acacia Pharma Group plc
1. Summary of the notification
Cambridge, UK and Indianapolis, US – 05 March 2021, 09:00 CET: Acacia Pharma Group plc has received a transparency notification dated 02 March 2021 indicating that Coltrane Asset Management L.P. now holds, by virtue of the purchase of shares on 18 February 2021, 5.50% of the voting rights of the company. Coltrane has therefore crossed the threshold of 5%.
2. Content of notification
The notification dated 2 March 2021 contains the following information:
Reason of the notification – acquisition or disposal of voting securities or voting rightsNotification by – a parent undertaking or a controlling personPersons subject to the notification requirement: